Delivery Order SPE2DB22D3501-SPE2DB25FXK77
Award Date 9/19/25
Potential Completion Date 10/10/25
Potential Value $8.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $17,009.24 delivery order to AmerisourceBergen Drug Corp for Tecentriq 840 mg/14 ml vials on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a major distribution hub for federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $17,009.24 to AmerisourceBergen Drug Corp for the supply of Tecentriq 840 mg/14 ml vials. This firm fixed-price, competitively awarded contract was issued on August 12, 2025, with an ultimate completion date of September 3, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside acquisition, this delivery order was open to competition among qualified...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Tecentriq 840 mg/14 ml vials. The contract is valued at $17,009.24 under a firm fixed-price arrangement with an ultimate completion date of May 15, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a $17,009.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for supply of Tecentriq (atezolizumab) 840 mg/14 mL vials on May 19, 2025, with completion targeted for June 10, 2025. This non-set-aside award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, which carries a $999,999,999 ceiling and runs through December 2026. The pharmaceutical distributor is...
- The Defense Logistics Agency awarded a $25,189 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tecentriq Hybridza 1,875 mg 15 ml pharmaceutical product. This is a non-set-aside competitive award with an ultimate completion date of September 30, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate...
- The Defense Logistics Agency awarded a $6,297.24 delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Tecentriq Hybreza 1,875 mg in 15 ml quantities. This contract represents a firm fixed-price delivery order with an ultimate completion date of May 13, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- This federal contract award, valued at $17,009.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TECENTRIQ 840 MG/14 ML VIAL 14ML, a specialty medication, to support military healthcare programs. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TECENTRIQ 840 MG/14 ML VIAL 14ML. This $8,016.30 contract has a completion date of March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors mentioned. The contract was awarded through DLA Troop Support Medical, which is responsible for supplying pharmaceuticals, medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TECENTRIQ HYBREZA 1,875 MG 15ML, a medical product, with a ceiling value of $6,297.24 and a period of performance ending on July 16, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Tecvayli 153 mg/1.7 mL vials. This firm fixed price delivery order, valued at $11,868.12, represents a competitively awarded non-set-aside procurement with an ultimate completion date of September 18, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...